Results 231 to 240 of about 92,349 (287)

Differential restoration of prothrombin time / INR in plasma from warfarin‐treated patients by various prothrombin complex concentrates (833.6)

open access: bronze, 2014
Schuharazad Abro   +5 more
openalex   +1 more source

The impact of immature granulocytes on the outcome of patients with decompensated cirrhosis

open access: yesEuropean Journal of Clinical Investigation, Volume 55, Issue 8, August 2025.
Immature granulocyte (IG) count and percentage had a predictive role in patients with decompensated cirrhosis, making them an objective and easily available marker of prognosis for this group of patients. In addition, IG percentage was the only factor independently associated with transplant‐free survival.
Magdalini Adamantou   +10 more
wiley   +1 more source

Immune Tolerance Induction With a Recombinant Factor VIII Fc in Haemophilia A: Data From a Chart Review Study

open access: yesEuropean Journal of Haematology, Volume 115, Issue 2, Page 134-141, August 2025.
ABSTRACT Objective To report data from an ITI chart review study (NCT03951103) for first‐time and rescue ITI with recombinant factor VIII Fc fusion protein (rFVIIIFc) in persons with haemophilia A. Methods Retrospective and prospective real‐world data are reported from a non‐interventional, multicentre study of patients who had been or were currently ...
Robert Klamroth   +7 more
wiley   +1 more source

Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries. [PDF]

open access: yesCan J Gastroenterol Hepatol, 2019
Wang HS   +5 more
europepmc   +1 more source

Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific

open access: yesInternational Journal of Laboratory Hematology, Volume 47, Issue 4, Page 720-729, August 2025.
ABSTRACT Introduction Activated protein C resistance (APCR) represents a risk factor for thrombosis and is usually due to factor V Leiden (FVL). Clinicians may order either test (i.e., APCR or FVL) to help assess ‘thrombophilia’ in patients who present with thrombosis. APCR testing is usually achieved using clot‐based assays, whereas FVL is assessed by
Emmanuel J. Favaloro   +8 more
wiley   +1 more source

Opportunities to improve surveillance of hepatocellular carcinoma in Australia

open access: yes
Medical Journal of Australia, EarlyView.
Jess Howell   +10 more
wiley   +1 more source

Surface Engineering of Thrombus‐Targeting Nanocarriers for Cardiovascular Diseases: A Short Review

open access: yesAdvanced Materials Interfaces, Volume 12, Issue 13, July 14, 2025.
This paper systematically introduces surface modification strategies for thrombus‐targeting nanocarriers, highlights the clinical significance of nanocarrier‐based thrombolysis therapies, and prospects the synergy of combing thrombolysis and anti‐inflammatory therapies for enhanced therapeutic effect.
Xinyue Ge   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy